A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis

NCT03379311 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Keratoconjunctivitis
Vernal Keratoconjunctivitis
Perennial Allergic Conjunctivitis

Interventions

DRUG: AK002

Sponsor

Allakos Inc.